Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
AILERON THERAPEUTICS INC (ALRN)
|
Add to portfolio |
|
|
|
| Price: |
$1.31
| | Metrics |
| OS: |
4.54
|
M
| |
|
|
| Market cap: |
$5.95
|
M
| |
|
|
|
Net cash:
|
$13.7
|
M
| |
$3.01
|
per share
|
|
EV:
|
|
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
|
| |
|
|
|
EBIT
|
|
| |
|
|
| EPS |
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
| Revenues | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Cost of goods sold | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Gross profit | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Selling, general and administrative | 27.6 | 26.6 | 20.5 | | | | | |
| Research and development | | | | 17.7 | 18.4 | 14.2 | 10.3 | 7.8 |
| General and administrative | | | | 12.3 | 13.5 | 8.8 | 7.9 | 5.1 |
| EBIT | -27.6 | -26.6 | -20.5 | -30.0 | -31.9 | -23.0 | -18.2 | -12.9 |
| Pre-tax income | -27.3 | -26.2 | -21.2 | -29.4 | -31.5 | -22.6 | -18.1 | -12.9 |
| Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | -27.3 | -26.2 | -21.2 | -29.4 | -31.5 | -22.6 | -18.2 | -12.9 |
| |
| Diluted EPS | ($6.02) | ($5.89) | ($0.61) | ($1.20) | ($2.14) | ($3.04) | ($42.35) | ($32.31) |
| Shares outstanding (diluted) | 4.5 | 4.4 | 34.9 | 24.5 | 14.7 | 7.4 | 0.4 | 0.4 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|